Mean of 19.5, 17.1, and 43.3% of participants did not maintain continuity of use of glucose, BP, lipid medications
Diagnosis & Disease Information
FDA Clears Automated Insulin Dosing App for Patients With Type 1 Diabetes
The prescription-only device works with integrated continuous glucose monitors and alternate controller enabled pumps.
Brenzavvy Approved for Adults With Type 2 Diabetes
The approval was based on data from a clinical program that included 23 clinical trials enrolling more than 5000 adults with type 2 diabetes mellitus.
Rybelsus Now First-Line Option for Type 2 Diabetes Following Label Update
Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Layered Approach Recommended for Patients With Diabetes, CKD
Layered approach involves initially combining lifestyle interventions, self-management, and first-line pharmacotherapy
Guidelines Updated for Reducing Hypoglycemia Risk in Diabetes
Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections
Glycemic Control Stagnant in US From 1988 to 2020
Mexican American adults receiving insulin less likely than non-Hispanic Whites to achieve glycemic control
First-Line Regimens With Endocrine Therapy Show Benefits in Breast Cancer
Findings seen among subgroup of patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Reduced risk seen for total knee replacement and total hip replacement with metformin use
